Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (531-540 of 550) with videos related to

Pageof 55
Sort By:
British Medical Journal|March 24, 1973
Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phaseL Schwarzenberg, G Mathé, P Pouillart, et al.
Cancer|October 1, 1974
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasG Mathé, L Schwarzenberg, P Pouillart, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1974
Immunoblastic acute lymphoid leukaemiaG Mathé, D Belpomme, D Dantchev, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]J L Misset, G Mathé, J Gastiaburu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisoneD Belpomme, F Simon, P Pouillart, et al.
Lancet (London, England)|March 27, 1982
Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoidJ Gouveia, G Mathé, T Hercend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up durationJ L Misset, M di Palma, M Delgado, et al.
Pageof 55

Showing results (531-540 of 550) with videos related to

Sort By:
Pageof 55
British Medical Journal|March 24, 1973
Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phaseL Schwarzenberg, G Mathé, P Pouillart, et al.
Cancer|October 1, 1974
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasG Mathé, L Schwarzenberg, P Pouillart, et al.
Cancer Treatment Reports|May 1, 1978
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristineG Mathé, J L Misset, F De Vassal, et al.
La Nouvelle Presse Medicale|May 3, 1975
[Active immunotherapy of acute leukemia and leukemic lymphosarcoma. Results of 10 years. Study of 200 cases]G Mathé, J L Amiel, L Schwarzenberg, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1977
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumoursG Mathé, B Serrou, M Hayat, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1974
Immunoblastic acute lymphoid leukaemiaG Mathé, D Belpomme, D Dantchev, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]J L Misset, G Mathé, J Gastiaburu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisoneD Belpomme, F Simon, P Pouillart, et al.
Lancet (London, England)|March 27, 1982
Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoidJ Gouveia, G Mathé, T Hercend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up durationJ L Misset, M di Palma, M Delgado, et al.
Pageof 55